Incidental Mutation 'R6048:Cln6'
ID 483395
Institutional Source Beutler Lab
Gene Symbol Cln6
Ensembl Gene ENSMUSG00000032245
Gene Name ceroid-lipofuscinosis, neuronal 6
Synonyms D9Bwg1455e, 1810065L06Rik
MMRRC Submission 044216-MU
Accession Numbers
Essential gene? Non essential (E-score: 0.000) question?
Stock # R6048 (G1)
Quality Score 225.009
Status Validated
Chromosome 9
Chromosomal Location 62746067-62759288 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) T to C at 62751908 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Leucine to Proline at position 44 (L44P)
Ref Sequence ENSEMBL: ENSMUSP00000034776 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000034776] [ENSMUST00000141821]
AlphaFold Q3U466
Predicted Effect probably damaging
Transcript: ENSMUST00000034776
AA Change: L44P

PolyPhen 2 Score 0.997 (Sensitivity: 0.41; Specificity: 0.98)
SMART Domains Protein: ENSMUSP00000034776
Gene: ENSMUSG00000032245
AA Change: L44P

DomainStartEndE-ValueType
Pfam:CLN6 27 306 1.3e-167 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000124984
SMART Domains Protein: ENSMUSP00000115675
Gene: ENSMUSG00000032245

DomainStartEndE-ValueType
Pfam:CLN6 1 64 1.3e-34 PFAM
Pfam:CLN6 68 189 2.7e-53 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000132250
Predicted Effect probably benign
Transcript: ENSMUST00000138276
Predicted Effect noncoding transcript
Transcript: ENSMUST00000139570
Predicted Effect probably benign
Transcript: ENSMUST00000141821
Predicted Effect noncoding transcript
Transcript: ENSMUST00000156423
Coding Region Coverage
  • 1x: 99.9%
  • 3x: 99.6%
  • 10x: 97.9%
  • 20x: 93.5%
Validation Efficiency 98% (60/61)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function. [provided by RefSeq, Oct 2008]
PHENOTYPE: Homozygous mutants have progressive retinal atrophy, limb paralysis, and seizures that lead to early death. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 62 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Aldh1a2 T C 9: 71,169,049 (GRCm39) I177T probably damaging Het
Aopep T A 13: 63,388,139 (GRCm39) F39L probably damaging Het
Arl4c A G 1: 88,629,350 (GRCm39) S13P possibly damaging Het
Bst1 G T 5: 43,976,306 (GRCm39) probably benign Het
Carmil3 G A 14: 55,741,302 (GRCm39) R1029Q probably benign Het
Cflar A G 1: 58,780,202 (GRCm39) T269A probably benign Het
Clcnka T A 4: 141,121,798 (GRCm39) Y236F probably damaging Het
Clmp T A 9: 40,682,405 (GRCm39) I63N probably damaging Het
Col5a3 C T 9: 20,718,915 (GRCm39) A280T unknown Het
Dact2 A G 17: 14,417,567 (GRCm39) L211P probably damaging Het
Dclk2 G T 3: 86,813,272 (GRCm39) Q225K probably damaging Het
Ddx60 T C 8: 62,453,616 (GRCm39) F1245S probably benign Het
Efcab3 A G 11: 104,835,259 (GRCm39) K3540E unknown Het
Eif3i T C 4: 129,487,145 (GRCm39) N240S probably benign Het
Enpp1 T C 10: 24,536,152 (GRCm39) Y416C probably damaging Het
Epb42 T A 2: 120,854,889 (GRCm39) R565S probably benign Het
Eral1 G A 11: 77,966,609 (GRCm39) P217L probably benign Het
Fbxl16 A G 17: 26,035,967 (GRCm39) Y188C probably benign Het
Fgd3 G A 13: 49,427,224 (GRCm39) P503S probably benign Het
Frem3 T C 8: 81,340,062 (GRCm39) L785P probably benign Het
Gadl1 A G 9: 115,835,769 (GRCm39) probably null Het
Gm10787 C T 10: 76,857,676 (GRCm39) noncoding transcript Het
Gm6563 A G 19: 23,653,246 (GRCm39) K12R probably benign Het
Grm5 T C 7: 87,675,758 (GRCm39) L424P probably damaging Het
H2ac11 A G 13: 22,227,006 (GRCm39) V31A probably benign Het
Il17re T C 6: 113,447,069 (GRCm39) S607P possibly damaging Het
Ints7 A G 1: 191,353,524 (GRCm39) probably benign Het
Itih1 A G 14: 30,651,780 (GRCm39) M854T possibly damaging Het
Kif1b A G 4: 149,348,086 (GRCm39) L315P probably damaging Het
Ms4a6b T C 19: 11,497,734 (GRCm39) V11A possibly damaging Het
Mxd1 C A 6: 86,627,966 (GRCm39) D191Y probably damaging Het
Nol8 T A 13: 49,807,160 (GRCm39) probably null Het
Ntn4 T A 10: 93,543,128 (GRCm39) probably null Het
Nxph1 A T 6: 9,247,103 (GRCm39) T25S probably benign Het
Or1n1 A G 2: 36,749,853 (GRCm39) V169A probably benign Het
Or2bd2 A C 7: 6,443,354 (GRCm39) T152P possibly damaging Het
Or3a1 A T 11: 74,225,961 (GRCm39) I32K probably benign Het
Or51f1d A G 7: 102,700,526 (GRCm39) N7S probably benign Het
Or5ac20 C T 16: 59,104,342 (GRCm39) V173I probably benign Het
Or6c219 A G 10: 129,781,695 (GRCm39) F79L possibly damaging Het
Oxsm T A 14: 16,242,308 (GRCm38) M154L possibly damaging Het
Papolg A C 11: 23,841,815 (GRCm39) I36S probably benign Het
Pde3b T A 7: 114,107,502 (GRCm39) H544Q probably benign Het
Pdzd2 A T 15: 12,592,656 (GRCm39) probably null Het
Prkce C A 17: 86,800,775 (GRCm39) P397Q probably benign Het
Ralgapa2 T C 2: 146,276,765 (GRCm39) S492G possibly damaging Het
Rnf216 A G 5: 143,054,659 (GRCm39) Y630H probably damaging Het
Ruvbl1 C T 6: 88,459,973 (GRCm39) T211I possibly damaging Het
Scyl2 A T 10: 89,481,348 (GRCm39) D666E probably benign Het
Sertad2 A G 11: 20,598,436 (GRCm39) T211A probably benign Het
Sipa1l1 A T 12: 82,487,643 (GRCm39) Q1639L probably benign Het
Snx5 T C 2: 144,101,073 (GRCm39) D98G probably damaging Het
Sorcs2 G T 5: 36,185,332 (GRCm39) probably null Het
Spmip2 T C 3: 79,313,192 (GRCm39) S89P probably damaging Het
Tanc2 G A 11: 105,758,543 (GRCm39) R768Q probably damaging Het
Tmem132d A G 5: 128,346,181 (GRCm39) S114P probably benign Het
Tns2 G A 15: 102,019,846 (GRCm39) G579R probably damaging Het
Usp37 A T 1: 74,517,295 (GRCm39) probably null Het
Vmn1r79 T C 7: 11,910,448 (GRCm39) I110T probably damaging Het
Vps37a C T 8: 40,981,363 (GRCm39) L69F probably damaging Het
Xirp2 T A 2: 67,338,587 (GRCm39) I276N possibly damaging Het
Zfp946 G A 17: 22,673,821 (GRCm39) E192K probably benign Het
Other mutations in Cln6
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01586:Cln6 APN 9 62,751,900 (GRCm39) missense probably damaging 0.98
IGL01601:Cln6 APN 9 62,754,252 (GRCm39) missense probably damaging 0.99
IGL02351:Cln6 APN 9 62,754,407 (GRCm39) missense probably benign 0.01
IGL02358:Cln6 APN 9 62,754,407 (GRCm39) missense probably benign 0.01
boost UTSW 9 62,754,375 (GRCm39) missense probably damaging 1.00
R1113:Cln6 UTSW 9 62,758,143 (GRCm39) missense probably damaging 1.00
R1308:Cln6 UTSW 9 62,758,143 (GRCm39) missense probably damaging 1.00
R3690:Cln6 UTSW 9 62,754,252 (GRCm39) missense possibly damaging 0.87
R3746:Cln6 UTSW 9 62,754,284 (GRCm39) missense probably benign
R3898:Cln6 UTSW 9 62,757,934 (GRCm39) missense probably damaging 1.00
R4576:Cln6 UTSW 9 62,746,231 (GRCm39) missense probably benign 0.35
R4996:Cln6 UTSW 9 62,757,937 (GRCm39) missense probably damaging 0.98
R5027:Cln6 UTSW 9 62,754,375 (GRCm39) missense probably damaging 1.00
R7348:Cln6 UTSW 9 62,756,458 (GRCm39) missense probably benign 0.14
R7450:Cln6 UTSW 9 62,757,912 (GRCm39) missense probably damaging 1.00
R7565:Cln6 UTSW 9 62,758,039 (GRCm39) missense possibly damaging 0.86
R7837:Cln6 UTSW 9 62,756,330 (GRCm39) missense
R7982:Cln6 UTSW 9 62,756,450 (GRCm39) missense possibly damaging 0.69
R9206:Cln6 UTSW 9 62,756,465 (GRCm39) missense probably benign 0.24
R9208:Cln6 UTSW 9 62,756,465 (GRCm39) missense probably benign 0.24
R9210:Cln6 UTSW 9 62,757,973 (GRCm39) missense probably damaging 1.00
R9212:Cln6 UTSW 9 62,757,973 (GRCm39) missense probably damaging 1.00
R9311:Cln6 UTSW 9 62,757,900 (GRCm39) missense probably damaging 1.00
R9369:Cln6 UTSW 9 62,754,431 (GRCm39) missense probably damaging 0.98
R9618:Cln6 UTSW 9 62,758,111 (GRCm39) missense probably damaging 0.99
R9627:Cln6 UTSW 9 62,754,303 (GRCm39) missense probably damaging 1.00
Predicted Primers PCR Primer
(F):5'- TCCAGTTTCCCATCTAGAAAGC -3'
(R):5'- ACTTCAAGGTGGGCTACAGG -3'

Sequencing Primer
(F):5'- CCCATCTAGAAAGCATGTATGTTCTG -3'
(R):5'- CACAGGATGACAACTGGGCC -3'
Posted On 2017-07-14